Mitoparan and target-selective chimeric analogues: membrane translocation and intracellular redistribution induces mitochondrial apoptosis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractMastoparan, and structurally-related amphipathic peptides, may induce cell death by augmentation of necrotic and/or apoptotic pathways. To more precisely delineate cytotoxic mechanisms, we determined that [Lys(5,8)Aib(10)]mastoparan (mitoparan) specifically induces apoptosis of U373MG and ECV304 cells, as demonstrated by endonuclease and caspase-3 activation and phosphatidylserine translocation. Live cell imaging confirmed that, following translocation of the plasma membrane, mitoparan specifically co-localizes with mitochondria. Complementary studies indicated that mitoparan induces swelling and permeabilization of isolated mitochondria, through cooperation with a protein of the permeability transition pore complex VDAC, leading to the release of the apoptogenic factor, cytochrome c. N-terminal acylation of mitoparan facilitated the synthesis of chimeric peptides that incorporated target-specific address motifs including an integrin-specific RGD sequence and a Fas ligand mimetic. Significantly, these sychnologically-organised peptides demonstrated further enhanced cytotoxic potencies. We conclude that the cell penetrant, mitochondriotoxic and apoptogenic properties of mitoparan, and its chimeric analogues, offer new insights to the study and therapeutic induction of apoptosis.
CitationBiochimica et Biophysica Acta - Molecular Cell Research, 1783(5): 849-863
JournalBiochimica et Biophysica Acta - Molecular Cell Research
CollectionsMolecular Pharmacology Research Group
- Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
- Authors: Jones S, Howl J
- Issue date: 2012 Jan 18
- The cationic tetradecapeptide mastoparan as a privileged structure for drug discovery: Enhanced antimicrobial properties of mitoparan analogues modified at position-14.
- Authors: Howl J, Howl L, Jones S
- Issue date: 2018 Mar
- Mastoparan peptide causes mitochondrial permeability transition not by interacting with specific membrane proteins but by interacting with the phospholipid phase.
- Authors: Yamamoto T, Ito M, Kageyama K, Kuwahara K, Yamashita K, Takiguchi Y, Kitamura S, Terada H, Shinohara Y
- Issue date: 2014 Sep
- Inflammation and apoptosis induced by mastoparan Polybia-MPII on skeletal muscle.
- Authors: Rocha T, de Barros LL, Fontana K, de Souza BM, Palma MS, da Cruz-Höfling MA
- Issue date: 2010 Jun 15
- Induction of mitochondrial permeability transition and cytochrome C release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells.
- Authors: Hirpara JL, Seyed MA, Loh KW, Dong H, Kini RM, Pervaiz S
- Issue date: 2000 Mar 1